- ING announces that it is writing off 300 million euros on its balance sheet because a number of assets have become less valuable due to the corona crisis. This concerns a so-called goodwill write-off, which refers to the market value of a company.
- The pharmaceutical company Janssen Vaccines from Leiden will start a trial with a potential corona vaccine in the Netherlands, Spain and Germany in September, reports NieuwsuurJanssen Vaccines has already started vaccine testing in Belgium and the US.
- The National Coordination Team for the Diagnostic Chain (LCDK), which purchases and manages test materials on behalf of the ministry, has “some concerns” about the testing capacity in the autumn. In the AD, project leader Edwin Boel says: “It remains a struggle to get enough delivered.”
- In the United States, Republicans in the Senate have presented a $1 trillion emergency package, writes The New York Times. In addition, unemployment benefits will be cut significantly. The chances are slim that Democrats will agree, despite the fact that current benefits end at the end of this month.
- In the second quarter NXP Semiconductors has been hit hard by falling demand from the automotive sector. The chipmaker – which saw its turnover fall by 18 percent – recorded a 35 percent drop in turnover at its division that makes chips for the automotive sector.
Nederlands